These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The use of recombinant human erythropoietin (EPO) to correct the anemia of end-stage renal disease: a progress report. Adamson W, Egrie JC, Browne JK, Downing MR, Eschbach W. Behring Inst Mitt; 1988 Aug; (83):188-92. PubMed ID: 3071336 [Abstract] [Full Text] [Related]
10. Treatment of anaemia of progressive renal failure with recombinant human erythropoietin. A preliminary report. Salim KA, Salim S, Mathew T. J Assoc Physicians India; 1992 Jan; 40(1):42-3. PubMed ID: 1634463 [Abstract] [Full Text] [Related]
15. Contemporary uses of erythropoietin in pregnancy: a literature review. Sienas L, Wong T, Collins R, Smith J. Obstet Gynecol Surv; 2013 Aug 08; 68(8):594-602. PubMed ID: 23921673 [Abstract] [Full Text] [Related]
16. Utilization of erythropoietin in the treatment of the anemia due to chronic renal failure. Drüeke T, Zins B, Naret C, Casadevall N, Goureau Y, Bererhi L, Peterlongo F, Castaigne JP, Zingraff J, Delons S. Adv Nephrol Necker Hosp; 1989 Aug 08; 18():187-206. PubMed ID: 2493715 [Abstract] [Full Text] [Related]